Hepatitis C

Type: Keyphrase
Name: Hepatitis C
First reported Apr 15 2014 - Updated 10 mins ago - 3 reports

U.S. Healthcare Usage and Spending Resumes Rise in 2013

Reuters Health InformationBy Bill BerkrotApril 16, 2014(Reuters) - Americans used more health services and spent more on prescription drugs in 2013, reversing a recent trend, though greater use of cheaper generic drugs helped control spending, according ... [Published American Journal of Public Health - 10 mins ago]
First reported 6 hours ago - Updated 5 hours ago - 2 reports

Enanta Pharmaceuticals Posts Detailed Data from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis

Enanta Pharmaceuticals, Inc., a research and development-focusedbiotechnology company dedicated to creating small molecule drugs in theinfectious disease field, announced that detailed results from AbbVie's... ... [Published HispanicBusiness.com - 5 hours ago]
First reported 18 hours ago - Updated 9 hours ago - 3 reports

02:25 New hepatitis C drug treatment 'shows promise'

"A new treatment for hepatitis C 'cured' 90% of patients with the infection in 12 weeks, scientists said," BBC News reports after a new drug protocol designed to target the protein that assists the spread of the virus through the body has shown promising ... [Published NewsRT.co.uk - 9 hours ago]
First reported Apr 14 2014 - Updated 21 hours ago - 5 reports

Hep C drugs to get TGA approval

Two of the new direct-acting antiviral drugs that are revolutionising the treatment of chronic hepatitis C have been recommended for approval in Australia by the Secretary to the Department of Health.Simeprevir, a NS3/4A protease inhibitor, was recommended ... [Published Gastroenterology Update - 23 hours ago]
First reported Apr 14 2014 - Updated 21 hours ago - 8 reports

Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?

With the release of phase 2 data from Merck   ( NYSE: MRK     ) and phase 3 data from Bristol-Myers Squibb  ( NYSE: BMY     ) , the race for the new hepatitis C combination treatment is heating up.While leader Gilead Sciences ( NASDAQ: GILD     ) waits ... [Published Motley Fool Discussion Boards - 21 hours ago]
First reported Apr 14 2014 - Updated 22 hours ago - 4 reports

Breakthrough treatment for hepatitis C

(Medical Xpress)—A breakthrough treatment for hepatitis C that halves treatment time has been developed in an international clinical trial that included The University of Queensland.The landmark study has been published in the New England Journal of Medicine ... [Published Medical Xpress - 22 hours ago]
First reported Apr 14 2014 - Updated 23 hours ago - 5 reports

AbbVie achieves response rate of 96% in Phase III trials of hepatitis C treatment

US drugmaker AbbVie (NYSE: ABBV) has revealed promising new results from its hepatitis C development program at the European Association for the Study of Liver’s (EASL) International Liver Congress 2014 in London.Data from a pivotal Phase III study TURQUOISE-II, ... [Published Pharma Letter - 23 hours ago]
First reported Apr 15 2014 - Updated Apr 15 2014 - 2 reports

Therapy for Hepatitis C — The Costs of Success

Entities: Hepatitis C
First reported Apr 14 2014 - Updated Apr 15 2014 - 6 reports

New drug combination proves effective in treating patients with HCV genotype 1

Treatment options for the 170 million people worldwide with chronic Hepatitis C Virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical ... [Published News-Medical.Net - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 3 reports

WHO Issues First Hepatitis C Guidelines

Top NewsApril 15, 2014The recommendations include increasing hepatitis C screening, liver damage mitigation and how to select appropriate treatment for chronic infections.AsianScientist (Apr. 15, 2014) – WHO has issued its first guidance for the treatment ... [Published Asian Scientist - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 3 reports

Hepatitis C patients may have ‘cure’ treatments available within a year

New combination treatments that can cure the vast majority of hepatitis C patients could be available to Irish patients within a year.Data on the new treatments, which are being developed by more than one pharmaceutical company, was presented at the International ... [Published Irish Times - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 4 reports

FAQ: The High Cost of Hepatitis C Drugs

Last week, the World Health Organization strongly endorsed 2 new oral drugs that fight hepatitis C, a liver-damaging virus. The WHO recommended that all 150 million people infected worldwide be assessed for these drug treatments. ... [Published WebMD Health - Apr 14 2014]
Entities: Hepatitis C, Drugs, Virus


...our clinical programs across all market segments," said Sumit Dutta , M D , MBA, Senior Vice President and Chief Medical Officer at Catamaran. "We are delivering smarter solutions, enabling critical connections and pioneering innovative interventions to empower our clients and members to maximize their healthcare dollar."
On that front, Kleinrock said, "We noted, that perhaps there's still some work to do."
...Dr Scott Brun, vice-president for pharmaceutical development at AbbVie, said: "This phase III trial is an important step in the development of veliparib and in potentially providing patients with squamous non-small cell lung cancer with a new treatment option." This comes after the company published positive data from a phase III trial of its new treatment for chronic hepatitis C last month

More Content

All (2460) | News (2108) | Reports (0) | Blogs (307) | Audio/Video (1) | Fact Sheets (12) | Press Releases (21)
sort by: Date | Relevance
Adding interferon to nucleoside antivirals may ... [Published Aidsmap - 4 mins ago]
Catamaran Corporation Reduces Overall Drug Tren... [Published Barchart - 5 mins ago]
U.S. Healthcare Usage and Spending Resumes Rise... [Published American Journal of Public Health - 10 mins ago]
San Antonio scientist may have discovered more ... [Published Big News Network - 15 mins ago]
FDA priority review status granted for hepatiti... [Published Project Inform - 17 mins ago]
EASL Recommendations (Guidelines) on Treatment ... [Published National AIDS Treatment Advocacy Project - 35 mins ago]
AbbVie announces phase III trial of lung cancer... [Published Zenopa - 40 mins ago]
Drug-addicted health professionals put patients... [Published Herald Times - 1 hour ago]
Senate panel takes up medical registry bill [Published Rock Hill Herald - 1 hour ago]
Merck announces encouraging interim results fro... [Published Individual.com - 1 hour ago]
Bristol-Myers announces encouraging results fro... [Published Individual.com - 1 hour ago]
‘Geographic lens’ may be key to HIV prevention [Published Brown Daily Herald - 1 hour ago]
Johnson & Johnson 1st-qtr 2014 results beat exp... [Published Pharma Letter - 1 hour ago]
Russian Law Corners Drug Users [Published Inter Press Service - 2 hours ago]
Sales of J&J's Hepatitis Drug Soar [Published BioPortfolio - 3 hours ago]
ABT-450/r–Ombitasvir and Dasabuvir with Ribavir... [Published NEJM Most Emailed Articles - 3 hours ago]
Coverage of the 2014 EASL International Liver C... [Published HIV and Hepatitis.com - 3 hours ago]
Researchers identify mechanism that explains re... [Published News-Medical.Net - 4 hours ago]
Enanta Pharmaceuticals Posts Detailed Data from... [Published HispanicBusiness.com - 5 hours ago]
Needle exchange scheme records rise [Published BBC - 5 hours ago]
ENANTA PHARMACEUTICALS : Posts Detailed Data fr... [Published 4 Traders - 6 hours ago]
ANALYSIS-Biotech stocks rout beginning to revea... [Published CNBC - 6 hours ago]
Johnson & Johnson posts earnings of $1.54 a sha... [Published DailyMe.Com - 6 hours ago]
These Siblings Have a Rare Genetic Mutation Tha... [Published Fooyoh - 7 hours ago]
Healthcare ‘usage, spending increased in ‘13’ [Published The Gulf Today - 7 hours ago]
Killer on parole during rampage [Published Nelson Mail - 9 hours ago]
02:25 New hepatitis C drug treatment 'shows pro... [Published NewsRT.co.uk - 9 hours ago]
Trial results for AbbVie’s Hepatitis C candidat... [Published Center Watch - 12 hours ago]
Aaron McDonald's history of violence [Published Nelson Mail - 12 hours ago]
How Much Has Merck Shaken Up the Hepatitis C Race? [Published Motley Fool Discussion Boards - 12 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
Content Volume
Document Volume


sort by: Date | Relevance
ABT-450/r–Ombitasvir and Dasabuvir with Ribavir... [Published NEJM Most Emailed Articles - 3 hours ago]
Breaking Bad Mitochondria [Published Scientific Blogging - 16 hours ago]
Researchers at the University of California, San Diego School of Medicine have identified a mechanism that explains why people with the hepatitis C virus get liver disease and why the virus is able to persist in the body for so long. The hard-to-kill ...
‘Major Breakthrough’ In Hepatitis C Treatment I... [Published Think Progress - 18 hours ago]
Advocates from AIDS Healthcare Foundation protest Gilead’s drug pricing CREDIT: John Storey/AP Images for AIDS Healthcare Foundation Solvadi, a new drug that can help combat hepatitis C, is being hailed as a “ turning point ” in the treatment of the ...
Frontrunning: April 15 [Published Zero Hedge - 23 hours ago]
Ukraine forces move against separatists ( FT ) China GDP Gauge Seen Showing Deeper Slowdown ( BBG ) China Is Losing Its Taste for Gold ( WSJ ) Regulators Weigh Curbs on Trading Fees ( WSJ ) Obama, Putin Talk as Unrest Roils Eastern Ukraine ( WSJ ) Japan ...
Top stories in health and medicine, April 15, 2014 [Published KevinMD.com - Apr 15 2014]
From   MedPage Today : A Different Take on .health Domains . Top level domains (TLD) like .doctor, .med, and .health will certainly provide for a memorable way to promote one’s practice website as compared with what exists today in domain name cho ...
1 2 3 4 5 6 7 8 9 10 ...


sort by: Date | Relevance
GM Puts Engineers On Leave [Published Wall Street Journal What's News - Apr 10 2014]

Press Releases

sort by: Date | Relevance
Idenix Announces Promising Clinical Data and Co... [Published GlobeNewswire: Acquisitions News - Apr 07 2014]
Annual Report 2013 [Published GlobeNewswire: Advertising News - Apr 07 2014]
Two phase III trials evaluating once-daily Sime... [Published GlobeNewswire: Advertising News - Apr 02 2014]
Simeprevir has now been approved in Russia [Published GlobeNewswire: Acquisitions News - Mar 24 2014]
Simeprevir receives positive CHMP opinion for t... [Published GlobeNewswire: Advertising News - Mar 21 2014]
1 2 3 4 5
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.